Control of thymidine incorporation in mucosal explants from patients with chronic ulcerative colitis.
D002471:Cell Transformation, Neoplastic; D003093:Colitis, Ulcerative / Q000378:metabolism*; D003106:Colon / Q000378:metabolism; D003110:Colonic Neoplasms / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D009924:Organ Culture Techniques; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011230:Precancerous Conditions / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism*; D013997:Time Factors
D010726:Phosphodiesterase Inhibitors; D004247:DNA; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D013936:Thymidine